DuPont de Nemours Stock: Analyst Estimates & RatingsAug 12, 2026DuPont de Nemours stock outperformed the S&P 500 driven by growth in water treatment and biopharma processing. Analysts maintain a Strong Buy rating with significant upside potential.DuPont de Nemours Stock: Analyst Estimates & RatingsinklTopic tracking2026-04-21UBS Raises Corteva Price Target to $88, Maintains Neutral Rating2026-04-22DuPont de Nemours Inc. Stock Underperforms vs Competitors on Wednesday2026-04-24DuPont’s Electronics Spinoff Qnity Prices $4.1B Debt Deal Ahead of November Split2026-04-24RBC Adjusts Price Target on DuPont de Nemours to $56 From $60, Maintains Outperform Rating2026-04-28Morgan Stanley Adjusts DuPont de Nemours Price Target to $52 From $44, Maintains Equal Weight Rating2026-05-03Pictet Asset Management Holding SA Has $7.65 Million Holdings in DuPont de Nemours, Inc.2026-05-03STRS Ohio Sells 58,382 Shares of DuPont de Nemours2026-05-04DuPont de Nemours Inc. Stock Outperforms Competitors Despite Losses on the Day2026-05-04DuPont (DD) Earnings Report Expected Tomorrow2026-05-07Deutsche Bank Adjusts DuPont de Nemours Price Target to $60 From $58, Maintains Buy RatingShow all 88 updatesFAQWhat is the current analyst rating for DuPont de Nemours (DD) stock, and what does it imply about expected price movement?+How has DuPont de Nemours’ stock performed compared to key market benchmarks over the past year and year-to-date?+
ChemBrief